Discover Tenders by Therapeutic Activity Mattress Sector

Find the most relevant tenders for Therapeutic Activity Mattress. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Therapeutic Activity Mattress tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Therapeutic Activity Mattress tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Nadroparin B01Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6261693

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6261602

EMD:Ref Document

Bid Value: Ref Document

458 Days Left

Activity Finder Community Venues Extension

Deadline: 10 Jun 2027

Great Britain

Ref. No.: 6240447

EMD:Ref Document

Bid Value: Ref Document

619 Days Left

Mississippi River Outlets Vicinity Of Venice Louisiana Baptiste Collette Bar Channel 24 2 Maintenance Dredging Plaquemines Parish Louisiana

Deadline: 13 Jun 2026

United States

Ref. No.: 6235651

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alitretinoin D11Ah04 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6230493

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Open House Contracts For Multiple Active Ingredients Active Ingredient Combinations

Deadline: 01 Jun 2026

Germany

Ref. No.: 6230074

EMD:Ref Document

Bid Value: Ref Document

245 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine J05Ar21 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6229869

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

458 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab C10Ax14 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227129

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bempedoic Acid C10Ax15 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227068

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine N06Ba12 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6225281

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept L04Ab01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224846

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab L04Ac05 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224416

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe C10Ba10 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6223493

EMD:Ref Document

Bid Value: Ref Document

244 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jun 2026

Germany

Ref. No.: 6223117

EMD:Ref Document

Bid Value: Ref Document

245 Days Left

Showing 30871 to 30885 of 31355 results

‹
1
2
...
2056
2057
2058
2059
2060
2061
2062
...
2090
2091
›

Discover Tenders by Therapeutic Activity Mattress Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Therapeutic Activity Mattress Sector

Filter Your Search

FREE Trial plan for all new users!